Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-31

Clinical Trial Update: Subthalamotomy by ExAblate Transcranial System to Treat Motor Features of Parkinson's Disease [NA]

View source ↗

Summary

This completed clinical trial evaluated MR-guided subthalamotomy with the ExAblate Transcranial System for motor features of Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ExAblate Transcranial System

Snippet

Sponsor: Fundación de investigación HM | Conditions: Parkinson's Disease | NA | Status: COMPLETED